Synopsis
Synopsis
0
CEP/COS
0
EU WC
0
NDC API
0
VMF
0
EDQM
0
USP
0
JP
0
Others
0
FDA Orange Book
0
Canada
0
Australia
0
South Africa
DRUG PRODUCT COMPOSITIONS
0
US Patents
0
US Exclusivities
0
Health Canada Patents
US Medicaid
NA
Regulatory FDF Prices
NA
0
API
0
FDF
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz


1. 2207-75-2
2. Oteracil Potassium
3. Oxonic Acid Potassium Salt
4. Allantoxanic Acid Potassium Salt
5. Potassium Azaorotate
6. Oxonic Acid, Potassium Salt
7. Potassium 4,6-dioxo-1,4,5,6-tetrahydro-1,3,5-triazine-2-carboxylate
8. Oxonate
9. Potassium 2,6-dihydroxytriazinecarboxylate
10. Potassium 4,6-dihydroxy-1,3,5-triazine-2-carboxylate
11. Oxonate, Potassium
12. 4r7ffa00rx
13. Oxonic Acid (potassium Salt)
14. Chebi:80230
15. Mfcd00010565
16. Allantoxanic Acid, Potassium Salt
17. Allantoxanic Acid, Monopotassium Salt
18. Potassiumoxonate
19. Nsc28841
20. Nsc-28841
21. Potassium Allantoxanate
22. Ncgc00166236-01
23. 5-azaoroticacid,potassiumsalt
24. Potassium Otastat
25. 5-azaorotic Acid, Potassium Salt
26. Potassium 1,4,5,6-tetrahydro-4,6-dioxo-1,3,5-triazine-2-carboxylate
27. Einecs 218-627-5
28. Nsc 28841
29. Potassium 4,6-dioxo-1h-1,3,5-triazine-2-carboxylate
30. Potassium S-triazine-2,4-dione-6-carboxylate
31. Unii-4r7ffa00rx
32. Dsstox_cid_26568
33. Dsstox_rid_81727
34. Dsstox_gsid_46568
35. Kox
36. Schembl339417
37. Oteracil Potassium[jan]
38. Chembl3184847
39. Dtxsid5046568
40. Oteracil Potassium [jan]
41. Act04739
42. Amy40569
43. Bcp06172
44. Oteracil Potassium [who-dd]
45. Tox21_112362
46. 1,4,5,6-tetrahydro-4,6-dioxo-s-triazine-2-carboxylic Acid, Potassium Salt
47. Akos006229816
48. Akos015961942
49. Akos015964230
50. Akos025116606
51. Ac-2039
52. 1,3,5-triazine-2-carboxylic Acid, 1,4,5,6-tetrahydro-4,6-dioxo-, Monopotassium Salt
53. S-1 Component Oteracil Potassium
54. As-13301
55. Hy-17511
56. Sy036250
57. Cas-2207-75-2
58. Teysuno Component Oteracil Potassium
59. Db-010118
60. Ft-0603597
61. O0164
62. Oteracil Potassium Component Of Teysuno
63. F14898
64. Q-100280
65. Q27149343
66. Potassium;4,6-dioxo-1h-1,3,5-triazine-2-carboxylate
| Molecular Weight | 195.17 g/mol |
|---|---|
| Molecular Formula | C4H2KN3O4 |
| Hydrogen Bond Donor Count | 2 |
| Hydrogen Bond Acceptor Count | 4 |
| Rotatable Bond Count | 1 |
| Exact Mass | 194.96823704 g/mol |
| Monoisotopic Mass | 194.96823704 g/mol |
| Topological Polar Surface Area | 111 Ų |
| Heavy Atom Count | 12 |
| Formal Charge | 0 |
| Complexity | 274 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 2 |
Global Sales Information
ABOUT THIS PAGE
70
PharmaCompass offers a list of Oteracil Potassium API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Oteracil Potassium manufacturer or Oteracil Potassium supplier for your needs.
Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Oteracil Potassium manufacturer or Oteracil Potassium supplier.
A Potassium otastat manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Potassium otastat, including repackagers and relabelers. The FDA regulates Potassium otastat manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Potassium otastat API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
click here to find a list of Potassium otastat manufacturers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PhamaCompass.
A Potassium otastat supplier is an individual or a company that provides Potassium otastat active pharmaceutical ingredient (API) or Potassium otastat finished formulations upon request. The Potassium otastat suppliers may include Potassium otastat API manufacturers, exporters, distributors and traders.
click here to find a list of Potassium otastat suppliers with USDMF, JDMF, KDMF, CEP, GMP, and COA related information on PharmaCompass.
A Potassium otastat DMF (Drug Master File) is a document detailing the whole manufacturing process of Potassium otastat active pharmaceutical ingredient (API) in detail. Different forms of Potassium otastat DMFs exist exist since differing nations have different regulations, such as Potassium otastat USDMF, ASMF (EDMF), JDMF, CDMF, etc.
A Potassium otastat DMF submitted to regulatory agencies in the US is known as a USDMF. Potassium otastat USDMF includes data on Potassium otastat's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Potassium otastat USDMF is kept confidential to protect the manufacturer’s intellectual property.
click here to find a list of Potassium otastat suppliers with USDMF on PharmaCompass.
The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.
The Potassium otastat Drug Master File in Japan (Potassium otastat JDMF) empowers Potassium otastat API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).
PMDA reviews the Potassium otastat JDMF during the approval evaluation for pharmaceutical products. At the time of Potassium otastat JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.
click here to find a list of Potassium otastat suppliers with JDMF on PharmaCompass.
In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.
Pharmaceutical companies submit a Potassium otastat Drug Master File in Korea (Potassium otastat KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Potassium otastat. The MFDS reviews the Potassium otastat KDMF as part of the drug registration process and uses the information provided in the Potassium otastat KDMF to evaluate the safety and efficacy of the drug.
After submitting a Potassium otastat KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Potassium otastat API can apply through the Korea Drug Master File (KDMF).
click here to find a list of Potassium otastat suppliers with KDMF on PharmaCompass.
Potassium otastat Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Potassium otastat GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, and more, enabling you to easily find the right Potassium otastat GMP manufacturer or Potassium otastat GMP API supplier for your needs.
A Potassium otastat CoA (Certificate of Analysis) is a formal document that attests to Potassium otastat's compliance with Potassium otastat specifications and serves as a tool for batch-level quality control.
Potassium otastat CoA mostly includes findings from lab analyses of a specific batch. For each Potassium otastat CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Potassium otastat may be tested according to a variety of international standards, such as European Pharmacopoeia (Potassium otastat EP), Potassium otastat JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Potassium otastat USP).